# US 2012/0083858 A1 · Pain modulation systems and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083858 A1
- Document ID: US20120083858A1
- Status: Published application
- Kind: A1
- Application number: 13/377,557
- Filed: 2010-06-11
- Published: 2012-04-05
- Earliest claimed: 2009-06-11
- Inventors: David Yarnitsky
- Web page: https://patentgrep.com/patent/US20120083858A1

## CPC

- A61N 1/36071: {Pain}
- A61H 39/002: {Using electric currents (electrotherapy A61N1/32)}
- A61N 1/0502: {Skin piercing electrodes}
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61H 2201/165: Wearable interfaces
- A61H 2201/5002: Means for controlling a set of similar massage devices acting in sequence at different locations on a patient
- A61H 2201/5005: for controlling frequency distribution, modulation or interference of a driving signal
- A61H 2201/5035: Several programs selectable
- A61H 2201/5041: control is restricted to certain individuals
- A61H 2201/5097: wireless
- A61N 1/36021: {for treatment of pain}
- A61N 1/36075: {Headache or migraine}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)

## Abstract

Systems and methods of conducing a conditioning modulation of pain perception are disclosed. The system includes a power source, an impulse generator, a controller and at least one electrode for the delivery of a therapeutic stimulation.

## Claims

### Claim 1

A system for conducing a conditioning modulation of pain perception (CPM) said system comprises:
[a] a power source;
[b] an impulse generator, electrically connected to said power source and receiving energy therefrom;
[c] a controller electrically connected to said impulse generator and controlling the operation thereof, and
[d] at least one electrode for the delivery of a therapeutic CPM stimulation, said electrode is electrically connected to said impulse generator;
wherein said controller is programmed with the regime for delivery of said therapeutic CPM stimulation;
wherein said therapeutic CPM stimulation is delivered by said electrode to peripheral nerve fibers;
wherein said therapeutic CPM stimulation is achieved via activation of the Diffuse Noxious Inhibitory Control (DNIC) mechanism.

### Claim 2 (depends on 1)

The system as in claim 1, further comprising at least one multi-site electrode.

### Claim 3 (depends on 1)

The system as in claim 1, further comprising at least one multi-site electrode with a common return ground point.

### Claim 4 (depends on 1)

The system as in claim 1, further comprising at least one multi-site electrode wherein each said sits comprises an individual return ground point.

### Claim 5 (depends on 1)

The system as in claim 1, wherein said controller is programmed to deliver said therapeutic CPM stimulation percutaneously.

### Claim 6 (depends on 1)

The system as in claim 1, wherein said controller is programmed to deliver said therapeutic CPM stimulation at sub-threshold levels, relatively to the subjective pain threshold of a patient.

### Claim 7 (depends on 1)

The system as in claim 1, further comprising at least one inductive coil associated with said power source.

### Claim 8 (depends on 1)

The system as in claim 1, wherein said controller further comprises a wireless communication module, for connection with an external programmer of said system.

### Claim 9 (depends on 1)

The system as in claim 1, wherein said electrode is adapted to be topicaly disposed on patient's skin.

### Claim 10 (depends on 1)

The system as in claim 1, wherein said electrode is adapted to be implanted subcutaneously.

### Claim 11 (depends on 1)

The system as in claim 1, wherein said system is implantable.

### Claim 12

A device for conducing a conditioning modulation of pain perception (CPM) said device comprises:
[a] a power source;
[b] an impulse generator, electrically connected to said power source and receiving energy therefrom;
[c] a controller electrically connected to said impulse generator and controlling the operation thereof, and
wherein said impulse generator is connectable to at least one electrode, implemented for the delivery of a therapeutic CPM stimulation to peripheral nerve fibers, and
wherein said controller is programmed with the regime for delivery of said therapeutic CPM stimulation, wherein said therapeutic CPM stimulation is associated with an activation of the Diffuse Noxious Inhibitory Control (DNIC) mechanism.

### Claim 13 (depends on 12)

The device as in claim 12, further comprising at least one electrode.

### Claim 14 (depends on 12)

The device as in claim 12, further comprising at least one multi-site electrode.

### Claim 15 (depends on 12)

The device as in claim 12, wherein said controller is programmed to deliver said therapeutic CPM stimulation percutaneously.

### Claim 16 (depends on 12)

The device as in claim 12, wherein said controller is programmed to deliver said therapeutic CPM stimulation at sub-threshold levels, relatively to the subjective pain threshold of a patient.

### Claim 17 (depends on 12)

The device as in claim 12, further comprising at least one inductive coil associated with said power source.

### Claim 18 (depends on 12)

The device as in claim 12, wherein said controller further comprises a wireless communication module, for connection with an external programmer of said device.

### Claim 19

A method of conducing a conditioning modulation of pain perception (CPM), said method comprises:
[a] identifying a patient;
[b] determining the CPM profile of said patient, comprising:
[i] subjecting said patient to a conditioning stimulus (CS);
[ii] subjecting said patient to a test stimuli (TS), jointly and severally to said conditioning stimulus (CS), and
[iii] rating the intensities of pain sensations evoked by said TS, respectively with and without said CS;
[iv] evaluating the difference between said ratings obtained with and without said CS; thereby assessing the susceptibility of said patient to CPM therapy;
[c] selecting at least one site suitable for the delivery of a therapeutic CPM stimulation;
wherein said selection is performed in accordance with the Diffuse Noxious Inhibitory Control (DNIC) paradigm;
[d] applying said therapeutic CPM stimulation to at least one said suitable site; thereby conducing the conditioning modulation of pain perception (CPM) by said subject.

### Claim 20 (depends on 19)

The method as in claim 19, further comprises determining a subjective pain threshold level of said patient.

### Claim 21 (depends on 19)

The method as in claim 19, wherein said therapeutic CPM stimulation is delivered at sub-threshold pain level relatively subjective pain threshold level of said patient.

### Claim 22 (depends on 19)

The method as in claim 19, wherein said selecting at least one location suitable for the delivery of a therapeutic CPM stimulation, comprises:
[a] determining a respective dermatome/s accosted with a localized pain;
[b] preselecting in accordance with said DNIC paradigm a plurality of dermatomes, application of stimulation to which is putatively to conduce a CPM effect;
[c] selecting from said plurality of preselected dermatomes at least one dermatome overlaying a site that physically/anatomically facilitates an efficient application of said CPM stimulation and/or implantation of an electrical electrode therefor.

### Claim 23 (depends on 19)

The method as in claim 19, wherein said selecting at least one location suitable for the delivery of a therapeutic CPM stimulation, comprises:
[a] diagnosing said patient for a non-localized pain;
[b] arbitrarily selecting at least one dermatome;
[c] applying a therapeutic CPM stimulation to said dermatome;
[d] empirically evaluating the conduced CPM effect;
[e] preselecting, in accordance with said DNIC paradigm and based upon said empirical evaluation, a plurality of dermatomes, application of stimulation to which is putatively to conduce a CPM effect, and
[f] selecting from said plurality of preselected dermatomes at least one dermatome overlaying a site that physically/anatomically facilitates an efficient application of said CPM stimulation and/or implantation of an electrical electrode therefor.

### Claim 24 (depends on 19)

The method as in claim 19, wherein said pain is an idiopathic or neuropathic pain.

### Claim 25 (depends on 19)

The method as in claim 19, wherein the indication for said therapeutic CPM stimulation is selected from the group consisting of: a diabetic neuropathy, uremic neuropathy, post herpetic neuralgia, post operative neuropathic pain, traumatic nerve lesions, chemotherapy in general and chemotherapy by vincristine, taxol, platinot, thalidomide, hereditary neuropathy, pesticide induced neuropathy, post-operative pains, fibromyalgia, temporomandibular diorders, irritable bowel syndrome, tension type headache, atypical facial pain, migraine, vulvar vestibulitis and low back pains.

### Claim 26 (depends on 19)

The method as in claim 19, wherein said therapeutic CPM stimulation is delivered percutaneously.

### Claim 27 (depends on 19)

The method as in claim 19, wherein said therapeutic CPM stimulation is delivered subcutaneously.
